Skip to content

Medical-device intelligence

LMH: Implant, Dermal, For Aesthetic Use

FDA product code LMH: Implant, Dermal, For Aesthetic Use. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LMH
FDA device name
Implant, Dermal, For Aesthetic Use
Device class
3
Regulation number
Not provided
Medical specialty
Unknown
Review panel
SU

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 7 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Apr 6, 2011 to Nov 15, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LMH · Implant, Dermal, For Aesthetic Use07

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
Revanesse Versa, PN40081Z-1146-2020 · LMHProllenium Medical Technologies Inc.RecallFeb 11, 2020FDA record creation date
Radiesse (+) Lidocaine, Injectable Implant 1.5cc, Rx only, P/N: 8063M0K1, Merz Aesthetics. Product Usage: RADIESSE is indicated for sub-dermal i…Z-2607-2016 · LMHMerz North America, Inc.RecallAug 19, 2016FDA classification date
Radiesse (+) Lidocaine Injectable Implant 1.5cc, P/N: 8063M0K1. Indicated for subdermal implantation for the correction of moderate to severe fa…Z-0366-2016 · LMHMerz North America, Inc.RecallDec 3, 2015FDA classification date
Vitagel; indicated in surgical procedures (other than in neurosurgical and ophthalmic) as an adjunct to hemostasis when control of bleeding by li…Z-1353-2015 · LMHOrthovita, Inc., dBA Stryker Orthobiologics.RecallMar 30, 2015FDA classification date
Enhancement Medical expression. model # EXP-150. Injectable Gel 1.5cc Syringe with hyaluronic acid concentration of 20 mg/ml. Product Usage…Z-2135-2014 · LMHEnhancement Medical, LLCRecallAug 8, 2014FDA classification date
MERZ AESTHETICS, Radiesse Volume Advantage 1.5 CC, Injectable Implant, Part Number 8071M0H1 and 8071M0K1, Sterile, Rx ONLY. Part Number 8071M4K1…Z-0145-2012 · LMHMerz Aesthetics, Inc.RecallNov 1, 2011FDA classification date
Radiesse, Injectable Implant - 1.3cc Syringe, Sterile, Sterilized Using Steam, Use Before 2013-01, Ref 8046M7, Lot 1024417, Manufactured by: BioF…Z-2221-2011 · LMHMerz Aesthetics, Inc.RecallMay 19, 2011FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗